Pharmacotherapy with Fluoxetine Restores Functional Connectivity from the Dentate Gyrus to Field CA3 in the Ts65Dn Mouse Model of Down Syndrome

Early Pharmacotherapy with Fluoxetine Rescues Dendritic Pathology in the Ts65Dn Mouse Model of Down Syndrome

(2012) Sandra Guidi et al.   BRAIN PATHOLOGY

Divergent Roles ofp75NTRand Trk Receptors in BDNF's Effects on Dendritic Spine Density and Morphology

(2012) Christopher A. Chapleau et al.   NEURAL PLASTICITY

APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome

(2011) Stefania Trazzi et al.   HUMAN MOLECULAR GENETICS

Is it possible to improve neurodevelopmental abnormalities in Down syndrome?

(2011) Renata Bartesaghi et al.   REVIEWS IN THE NEUROSCIENCES

Widespread Proliferation Impairment and Hypocellularity in the Cerebellum of Fetuses with Down Syndrome

(2010) Sandra Guidi et al.   BRAIN PATHOLOGY

Three-dimensional synaptic ultrastructure in the dentate gyrus and hippocampal area CA3 in the Ts65Dn mouse model of down syndrome

(2010) Victor I. Popov et al.   JOURNAL OF COMPARATIVE NEUROLOGY

Early Pharmacotherapy Restores Neurogenesis and Cognitive Performance in the Ts65Dn Mouse Model for Down Syndrome

(2010) P. Bianchi et al.   JOURNAL OF NEUROSCIENCE

Restoration of Norepinephrine-Modulated Contextual Memory in a Mouse Model of Down Syndrome

(2009) A. Salehi et al.   Science Translational Medicine

Mental retardation and associated neurological dysfunctions in Down syndrome: A consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways

(2008) Mohammed Rachidi et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Abnormal expression of synaptic proteins and neurotrophin-3 in the down syndrome mouse model Ts65Dn

(2008) G. Pollonini et al.   NEUROSCIENCE